Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 2; p. e35395
• Main Authors: Hiremath, Jagdish, Mohan, J C, Hazra, Prakash, Sawhney, JP S, Mehta, Ashwani, Shetty, Sadanand, Oomman, Abraham, Shah, Mahesh K, Bantwal, Ganapathi, Agarwal, Rajeev, Karnik, Rajiv, Jain, Peeyush, Ray, Saumitra, Das, Sambit, Jadhao, Vibhuti, Suryawanshi, Sachin, Barkate, Hanmant
• Format: Journal Article
• Language: English
• Published: United States Springer Nature B.V 24.02.2023; Cureus
• Subjects: Acids; Apolipoproteins; C-reactive protein; Cardiology; Cholesterol; Clinical trials; Contraindications; Diabetes; Drug dosages; Enzymes; High density lipoprotein; Internal Medicine; Lipids; Lipoproteins; Liver; Statins; Therapeutics; cardiovascular disease; bempedoic acid; lipid lowering agents; india; c-reactive protein

Lipid-lowering is a central theme in the management of patients with atherosclerotic cardiovascular disease (ASCVD) and heterozygous familial hypercholesterolemia (HeFH), with statins being currently used as the first-line lipid-lowering agent (LLAs). Bempedoic acid (BA) has been recently approved f...